BOSTON, Sept. 15 – “We’ve got a large tasks ahead of us” explaining the role of pharmacogenomics in medical and healthcare practice, said Wayne Rosenkrans, director of Business Strategy, External Scientific Affairs at AstraZeneca Pharmaceuticals, during a panel discussion today at the IBC Molecular Diagnostics and Personalized Medicine conference.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.